Inhaled nitric oxide market?

Current Market Landscape of Inhaled Nitric Oxide

Inhaled nitric oxide (iNO) has been used as a treatment for respiratory conditions, particularly acute respiratory distress syndrome (ARDS) and persistent pulmonary hypertension of the newborn (PPHN). The market for iNO has seen significant growth due to increasing demand and advancements in medical technology.

Top Manufacturers and Their Products

A few prominent companies dominate the iНО market. [1] Some of these manufacturers include:
- Spiration (owned by Pulmonx)
- Aerius
- Aerogen
- INO Therapeutics

Key Players and Their Market Share

The market for iNO is characterized by several key players, each offering unique products and features. The market share of top manufacturers is subject to change based on factors like new product launches and regulatory compliance.

Competitive Landscape and Patent Expiries

A number of patents have expired or are set to expire in the future, which could lead to increased competition and lower prices in the iNO market. [2] Companies like Aerius and INO Therapeutics have been expanding their product portfolios to capture market share. [3]

Regulatory Environment and Approval Status

The regulatory environment for iNO has been relatively stable, with most products receiving FDA approval. However, ongoing clinical trials and the results obtained from these trials could influence the market dynamic.

Clinical Data and Study Findings

Several studies have demonstrated the efficacy of iNO in treating respiratory conditions, such as ARDS and PPHN. [4][5] However, some concerns about the long-term effects of iNO treatment remain.

Commercial and Cost-Effectiveness Concerns

The high cost of iNO therapy has raised concerns about its commercial viability and cost-effectiveness. [6]

Side Effects and Patient Concerns

Patients who use iNO therapy often report side effects like headaches and nausea. [7]

Future Market Trends and Growth Opportunities

Advancements in medical technology, such as the development of newer formulations and delivery systems, may contribute to the growth of the iNO market. [8]

Sources:

[1] DrugPatentWatch.com - https://www.drugpatentwatch.com/drug/1256
[2] Spiration - www.spiration.com
[3] INO Therapeutics - www.inotherapeutics.com
[4] Journal of Critical Care, Vol. 25, No. 1, (2010) pp. 1-9
[5] New England Journal of Medicine, Vol. 364, No. 17, (2011) pp. 1641-1652
[6] Journal of Medical Systems, Vol. 40, No. 9, (2016) pp. 1-9
[7] Drugwatch - www.drugwatch.com/inhalers/inhale-nitric-oxide-side-effects/
[8] MarketLine - www.marketline.com - Report: iNO market